|
|
 |
| |
|
|
| |
|
|
| |
|
| Synonyms: |
* Triclabendazolum [INN-Latin],
* Fasinex,
* 5-Chloro-6-(2,3-dichlorophenoxy)-2-(methylthio)benzimidazole,
* 1H-BENZIMIDAZOLE, 5-CHLORO-6-(2,3-DICHLOROPHENOXY)-2-(METHYLTHIO)-,
* 5-Chloro-6-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzimidazole,
* 6-Chloro-5-(2,3-dichlorophenoxy)-2-methylthio-benzimidazole,
* CGA 89317, * Triclabendazol [INN-Spanish],
* Triclabendazole [BAN:INN],
* ZINC00538495,
* ZINC01444556
|
| Chemical Name: |
6-chloro-5-(2,3-dichlorophenoxy)-2-methylsulfanyl-1H-benzoimidazole |
| Molecular Formula: |
|
| Molecular Weight : |
359.658 |
| CAS No. : |
68786-66-3 |
| Chemical Structure: |
|
| Specification: |
CPV |
Pharmacodynamic
Properties: |
Triclabendazole is a benzimidazole. It binds to tubulin impairing intracellular transport mechanisms and interferes with protein synthesis. Triclabendazole is specifically active against Fasciola, Fascioloides and Paragonimus.
Triclabendazole is specifically effective against all 3 stages of Fasciola. The unique efficacy against early immature and immature stages makes it particularly useful for the treatment of outbreaks of acute and subacute fasciolosis and for the strategic control of Fasciola infections.
|
| Storage: |
Keep container tightly closed in a cool, well-ventilated area. |
| MSDS: |
Provide as per request after the order or contract is signed. |
|
|
| |
[Disclaimer]
(1) All rights reserved. Reproduction in whole or part expressly forbidden without written permission.
(2) We make effort to ensure the information presented here is accurate, but does not purport to be all inclusive and shall be used only as a reference.
(3) We make no warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. |
|
 |
|
|
